<code id='56E0A575C1'></code><style id='56E0A575C1'></style>
    • <acronym id='56E0A575C1'></acronym>
      <center id='56E0A575C1'><center id='56E0A575C1'><tfoot id='56E0A575C1'></tfoot></center><abbr id='56E0A575C1'><dir id='56E0A575C1'><tfoot id='56E0A575C1'></tfoot><noframes id='56E0A575C1'>

    • <optgroup id='56E0A575C1'><strike id='56E0A575C1'><sup id='56E0A575C1'></sup></strike><code id='56E0A575C1'></code></optgroup>
        1. <b id='56E0A575C1'><label id='56E0A575C1'><select id='56E0A575C1'><dt id='56E0A575C1'><span id='56E0A575C1'></span></dt></select></label></b><u id='56E0A575C1'></u>
          <i id='56E0A575C1'><strike id='56E0A575C1'><tt id='56E0A575C1'><pre id='56E0A575C1'></pre></tt></strike></i>

          fashion

          fashion

          author:hotspot    Page View:17427
          Illustration of a hospital with stacks of dollar bills on top – private equity coverage from STAT
          Adobe

          Private equity firms are rapidly buying their way into the U.S. health care system, and as they do, new research finds they tend to increase costs and may also harm quality.

          A new BMJ systematic review rounded up 55 studies on the effects of private equity buyouts in health care globally to flesh out an overarching conclusion. The team of researchers found that private equity ownership generally means higher costs for patients, insurance companies, and government programs. The effects on quality were mixed, with more evidence showing that such financial investors degrade quality.

          advertisement

          “This is really the first widespread snapshot of what the impacts of all these developments are,” said Alexander Borsa, a study author and doctoral candidate at Columbia University.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more
          Biotech investment managers search for lucrative opportunities
          Biotech investment managers search for lucrative opportunities

          Fromleft,RodNathan,portfoliomanagerandpartnerofJ.Goldman&Co.;ARKInvestsenioranalystAliUrman;andP

          read more
          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more

          Feng Zhang suggests Editas didn’t move quickly enough to find product targets

          ScientistFengZhang,right,isinterviewedbyreporterMeganMolteniatSTAT'sBreakthroughSummitEast.STATWhent